Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Nintedanib Induction for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
jRCT1031250668Recruiting
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nintedanib in idiopathic pulmonary fibrosis (IPF). Started Jan 2026; status: recruiting.
02
Drugs
nintedanib
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on jRCT1031250668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250668.